Neurocrine Biosciences
NBIX
#1411
Rank
A$22.12 B
Marketcap
A$220.03
Share price
-1.41%
Change (1 day)
18.66%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Cost to borrow NBIX shares - Neurocrine Biosciences

Latest borrow fee for Neurocrine Biosciences (NBIX) shares on Interactive Brokers: 0.2782% (annualized)

Shares available to borrow: 3800000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Neurocrine Biosciences (NBIX) - cost to borrow in the last 7 days chart

Neurocrine Biosciences (NBIX) - number of shares available to borrow in the last 7 days

Neurocrine Biosciences (NBIX) - cost to borrow from 2026 to 2023

Neurocrine Biosciences (NBIX) - number of shares available to borrow from 2026 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
Pfizer
PFE
0.25%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
0.4081%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
0.4135%8.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
0.25%0.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
29.7439%1.6 M๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
0.2782%0.2 M๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
10.9092%0.02 M๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
0.2789%6.2 M๐Ÿ‡ฌ๐Ÿ‡ง UK